These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 21787286

  • 1. Potential anti-catabolic and anabolic properties of strontium ranelate.
    Mentaverri R, Brazier M, Kamel S, Fardellone P.
    Curr Mol Pharmacol; 2012 Jun; 5(2):189-94. PubMed ID: 21787286
    [Abstract] [Full Text] [Related]

  • 2. Strontium ranelate improves bone microarchitecture in osteoporosis.
    Hamdy NA.
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
    [Abstract] [Full Text] [Related]

  • 3. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
    Shiraki M.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():447-53. PubMed ID: 18161147
    [No Abstract] [Full Text] [Related]

  • 4. The effect of PTH(1-84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial.
    Quesada-Gómez JM, Muschitz C, Gómez-Reino J, Greisen H, Andersen HS, Dimai HP.
    Osteoporos Int; 2011 Sep 28; 22(9):2529-37. PubMed ID: 21052638
    [Abstract] [Full Text] [Related]

  • 5. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
    Gallacher SJ, Dixon T.
    Calcif Tissue Int; 2010 Dec 28; 87(6):469-84. PubMed ID: 20872215
    [Abstract] [Full Text] [Related]

  • 6. Strontium ranelate: a look back at its use for osteoporosis.
    Reginster JY, Neuprez A.
    Expert Opin Pharmacother; 2010 Dec 28; 11(17):2915-27. PubMed ID: 21050035
    [Abstract] [Full Text] [Related]

  • 7. How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis.
    Marie PJ, Felsenberg D, Brandi ML.
    Osteoporos Int; 2011 Jun 28; 22(6):1659-67. PubMed ID: 20812008
    [Abstract] [Full Text] [Related]

  • 8. Strontium ranelate in osteoporosis and beyond: identifying molecular targets in bone cell biology.
    Marie PJ.
    Mol Interv; 2010 Oct 28; 10(5):305-12. PubMed ID: 21045244
    [Abstract] [Full Text] [Related]

  • 9. Strontium ranelate and risk of vertebral fractures in frail osteoporotic women.
    Rolland Y, Abellan Van Kan G, Gillette-Guyonnet S, Roux C, Boonen S, Vellas B.
    Bone; 2011 Feb 28; 48(2):332-8. PubMed ID: 20817053
    [Abstract] [Full Text] [Related]

  • 10. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.
    Tat SK, Pelletier JP, Mineau F, Caron J, Martel-Pelletier J.
    Bone; 2011 Sep 28; 49(3):559-67. PubMed ID: 21700005
    [Abstract] [Full Text] [Related]

  • 11. Long-term effect of strontium ranelate treatment on BMD.
    Blake GM, Fogelman I.
    J Bone Miner Res; 2005 Nov 28; 20(11):1901-4. PubMed ID: 16234961
    [No Abstract] [Full Text] [Related]

  • 12. [Strontium ranelate for osteoporosis treatment].
    Kurth A.
    Orthopade; 2014 Feb 28; 43(2):181. PubMed ID: 24693555
    [No Abstract] [Full Text] [Related]

  • 13. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
    Marie PJ.
    Bone; 2006 Feb 28; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
    [Abstract] [Full Text] [Related]

  • 14. Anabolic skeletal therapy for osteoporosis.
    Girotra M, Rubin MR, Bilezikian JP.
    Arq Bras Endocrinol Metabol; 2006 Aug 28; 50(4):745-54. PubMed ID: 17117299
    [Abstract] [Full Text] [Related]

  • 15. The action of Strontium ranelate: myth or reality.
    Bunyaratavej N.
    J Med Assoc Thai; 2011 Oct 28; 94 Suppl 5():S35-7. PubMed ID: 22338924
    [Abstract] [Full Text] [Related]

  • 16. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
    Adami S.
    Bone; 2006 Feb 28; 38(2 Suppl 1):23-7. PubMed ID: 16434247
    [Abstract] [Full Text] [Related]

  • 17. The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate.
    Middleton ET, Steel SA, Aye M, Doherty SM.
    J Bone Miner Res; 2010 Mar 28; 25(3):455-62. PubMed ID: 20201000
    [Abstract] [Full Text] [Related]

  • 18. Strontium ranelate: a physiological approach for an improved bone quality.
    Ammann P.
    Bone; 2006 Feb 28; 38(2 Suppl 1):15-8. PubMed ID: 16455318
    [Abstract] [Full Text] [Related]

  • 19. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
    Kaliterna DM.
    Reumatizam; 2008 Feb 28; 55(2):73-4. PubMed ID: 19024281
    [Abstract] [Full Text] [Related]

  • 20. Improvement in bone strength parameters. The role of strontium ranelate.
    Tournis S.
    J Musculoskelet Neuronal Interact; 2007 Feb 28; 7(3):266-7. PubMed ID: 17947810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.